Amphastar Pharmaceuticals Inc vs Zscaler Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Zscaler Inc trades at $176.6 (market cap $28.87B). The key difference: Zscaler Inc is far larger — about 33.2× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMPH | ZS | |
|---|---|---|
Market Cap | $868.62M | $28.87B |
Sector | Health | Technology |
52-Week High | $30.81 | $336.27 |
52-Week Low | $16.87 | $118.05 |
Enterprise Value | $1.27B | $27.20B |
Trailing returns across standard periods
Latest headlines on both assets
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →